Sio Capital Management, LLC Savara Inc Transaction History

Sio Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$2.97 - $3.88 $339,919 - $444,069	-114,451 Reduced 11.32%	896,250 $3.39 Million
Q2 2023 Aug 14, 2023	BUY	$1.69 - $3.24 $105,192 - $201,670	62,244 Added 6.56%	1,010,701 $3.22 Million
Q1 2023 May 12, 2023	BUY	$1.6 - $2.82 $131,214 - $231,265	82,009 Added 9.46%	948,457 $1.85 Million
Q4 2022 Feb 13, 2023	BUY	$1.11 - $1.64 $11,122 - $16,432	10,020 Added 1.17%	866,448 $1.34 Million
Q2 2022 Aug 15, 2022	BUY	$1.1 - $1.58 $154,182 - $221,462	140,166 Added 19.57%	856,428 $1.3 Million
Q1 2022 May 16, 2022	BUY	$1.05 - $1.36 $68,346 - $88,525	65,092 Added 10.0%	716,262 $938,000
Q4 2021 Feb 14, 2022	BUY	$1.04 - $1.34 $677,216 - $872,567	651,170 New	651,170 $807,000
Q3 2019 Nov 14, 2019	SELL	$2.16 - $3.2 $864,000 - $1.28 Million	-400,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.37 - $11.7 $948,000 - $4.68 Million	400,000 New	400,000 $948,000

129

158M

67.6K

29.4K

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $377M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.